Stay Informed

Our peer-reviewed journals, feature your noteworthy discoveries and important scientific advances that shape the future of hormone health

  • Endocrine Reviews—Publishes authoritative review articles on research topics in endocrinology and related areas
  • Endocrinology—Disseminates emerging hormone science to scientists, clinicians, and the public.
  • Journal of the Endocrine Society—Publishes research, tools, methods, databases, images, and other advances in basic science, clinical science, and clinical practice in endocrinology.
  • The Journal of Clinical Endocrinology and Metabolism—Publishes clinical research and practice information in the pathophysiology, diagnosis, and treatment of endocrine and metabolic disorders.

We also offer monthly, curated, Thematic Issues of journal articles; News, updates, editorials, and more in our member magazine Endocrine News; and audio on-the-go with the Endocrine News Podcast, spotlighting breakthroughs in hormone science.

In Endocrine News

Ashley Herdman Describes her REGMS Experience

For medical and graduate students with a keen career interest in endocrine research, the Research Experiences for Graduate and Medical Students (REGMS) summer program has proven to be a worthy benefit — offering invaluable lab experiences, networking connections, and mentorships that last well beyond the summer months. Ashley Herdman, one of the 2021 awardees, describes her experience with REGMS.

For medical and graduate students with a keen career interest in endocrine research, the Research Experiences for Graduate and Medical Students (REGMS) summer program has proven to be a worthy benefit — offering invaluable lab experiences, networking connections, and mentorships that last well beyond the summer months. Ashley Herdman, one of the 2021 awardees, describes her experience with REGMS.

In Endocrine News

Increased Risk of Hearing Impairment with TED Treatment

More patients than previously reported may experience hearing symptoms such as hearing loss or muffled hearing from a new treatment for thyroid eye disease TED), teprotumumab (Tepezza), according to a small study presented virtually at ENDO 2021. Teprotumumab, approved by the U.S. Food and Drug Administration in January 2020, is the first and only drug to be approved for TED.

More patients than previously reported may experience hearing symptoms such as hearing loss or muffled hearing from a new treatment for thyroid eye disease TED), teprotumumab (Tepezza), according to a small study presented virtually at ENDO 2021. Teprotumumab, approved by the U.S. Food and Drug Administration in January 2020, is the first and only drug to be approved for TED.

Thematic Issues
Publishing Your Research

Tips on Getting Published in Endocrine Society Journals

Carol A. Lange, PhD, Editor-in-Chief of Endocrinology, and Stephen R. Hammes, MD, PhD, past Editor-in-Chief of Molecular Endocrinology share critical tips on how to get published.

Carol A. Lange, PhD, Editor-in-Chief of Endocrinology, and Stephen R. Hammes, MD, PhD, past Editor-in-Chief of Molecular Endocrinology share critical tips on how to get published.

Grants & Funding

Research Opportunities

Research Policy
Explore resources for pursuing endocrine-related research opportunities.
Grants & Funding

Research Opportunities

Explore resources for pursuing endocrine-related research opportunities.

Actions & Opportunities

Advocacy Calendar

Our advocacy calendar provides a global overview of upcoming legislative and regulatory deadlines and events.
Actions & Opportunities

Advocacy Calendar

Our advocacy calendar provides a global overview of upcoming legislative and regulatory deadlines and events.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.